Prologue by Emma Guttman-Yassky

Get full text

Molecular and Cellular Profiling of Scalp Psoriasis Reveals Differences and Similarities Compared to Skin Psoriasis. by Juan Ruano, Mayte Suárez-Fariñas, Avner Shemer, Margeaux Oliva, Emma Guttman-Yassky, James G Krueger

Get full text

Successful treatment of juvenile pityriasis rubra pilaris with ustekinumab in a 7-year-old girl by Lauren Bonomo, BA, Aishwarya Raja, BS, Kathryn Tan, MD, Emma Guttman-Yassky, MD, PhD

Get full text

RNA Sequencing Keloid Transcriptome Associates Keloids With Th2, Th1, Th17/Th22, and JAK3-Skewing by Jianni Wu, Jianni Wu, Ester Del Duca, Ester Del Duca, Michael Espino, Alyssa Gontzes, Inna Cueto, Ning Zhang, Yeriel D. Estrada, Ana B. Pavel, Ana B. Pavel, James G. Krueger, James G. Krueger, Emma Guttman-Yassky, Emma Guttman-Yassky

Get full text

Effective use of ustekinumab in a patient with concomitant psoriasis, vitiligo, and alopecia areata by Amal Elkady, MBBCh, Lauren Bonomo, BA, Yasmin Amir, MD, Anjali S. Vekaria, MD, Emma Guttman-Yassky, MD, PhD

Get full text

Safety and Efficacy of Ritlecitinib and Brepocitinib in Alopecia Areata: Results from the Crossover Open-Label Extension of the ALLEGRO Phase 2a Trial by Brett King, Emma Guttman-Yassky, Elena Peeva, Anindita Banerjee, Linda Zhu, Hua Zhu, Lori Ann Cox, Michael S. Vincent, Rodney Sinclair

Get full text

Th2/Th1 Cytokine Imbalance Is Associated With Higher COVID-19 Risk Mortality by Ana B. Pavel, Ana B. Pavel, Jacob W. Glickman, James R. Michels, Seunghee Kim-Schulze, Rachel L. Miller, Emma Guttman-Yassky

Get full text

Eosinophil count, serum CCL17/18/26 and immunoglobulin E levels in atopic dermatitis: upadacitinib phase 2 study analysis by Emma Guttman-Yassky, Ana B. Pavel, Jonathan Silverberg, Stephan Weidinger, Julie Parmentier, Henrique D. Teixeira, Feng Hong, Lisa A. Beck, Bjoern Wolff

Get full text

Tape-Strip Proteomic Profiling of Atopic Dermatitis on Dupilumab Identifies Minimally Invasive Biomarkers by Helen He, Caroline M. Olesen, Ana B. Pavel, Maja-Lisa Clausen, Jianni Wu, Yeriel Estrada, Ning Zhang, Tove Agner, Emma Guttman-Yassky

Get full text

Rocatinlimab Improves Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis: Results from a Double-Blind Placebo-Controlled Phase 2b Study by Melinda Gooderham, Emma Guttman-Yassky, Ken Igawa, Kenji Kabashima, Ehsanollah Esfandiari, Angela J. Rylands, Angela Williams, Annabel Nixon, Jennifer E. Dent, Eric Simpson

Get full text

Correction to: Qualitative Assessment of Adult Patients’ Perception of Atopic Dermatitis Using Natural Language Processing Analysis in a Cross-Sectional Study by Bruno Falissard, Eric L. Simpson, Emma Guttman-Yassky, Kim A. Papp, Sebastien Barbarot, Abhijit Gadkari, Grece Saba, Laurene Gautier, Adeline Abbe, Laurent Eckert

Get full text

Qualitative Assessment of Adult Patients’ Perception of Atopic Dermatitis Using Natural Language Processing Analysis in a Cross-Sectional Study by Bruno Falissard, Eric L. Simpson, Emma Guttman-Yassky, Kim A. Papp, Sebastien Barbarot, Abhijit Gadkari, Grece Saba, Laurene Gautier, Adeline Abbe, Laurent Eckert

Get full text

Efficacy and safety of abrocitinib in patients with moderate‐to‐severe atopic dermatitis with prior exposure to oral systemic immunosuppressants or biologic therapies: A post hoc a... by Melinda J. Gooderham, Michael R. Ardern‐Jones, Emma Guttman‐Yassky, Mahreen Ameen, Eric L. Simpson, Gary Chan, Pinaki Biswas, Wing S. Chiu, Melissa Watkins

Get full text

Protocol for a prospective, observational, longitudinal study in paediatric patients with moderate-to-severe atopic dermatitis (PEDISTAD): study objectives, design and methodology by Alan D Irvine, Amy S Paller, Emma Guttman-Yassky, Eulalia Baselga, Marjolein de Bruin-Weller, Shyamalie Jayawardena, Annie Zhang, Paola Mina-Osorio, Elena Rizova, Zafer E Ozturk

Get full text

Changes in Skin and Nasal Microbiome and Staphylococcal Species Following Treatment of Atopic Dermatitis with Dupilumab by Caroline Meyer Olesen, Anna Cäcilia Ingham, Simon Francis Thomsen, Maja-Lisa Clausen, Paal Skytt Andersen, Sofie Marie Edslev, Yasemin Topal Yüksel, Emma Guttman-Yassky, Tove Agner

Get full text

The use of biologic medications for the treatment of cutaneous immune-related adverse events secondary to immune checkpoint inhibitors: A single-institution real-life study by Jade N. Young, BS, Hannah Verma, BA, Nour El Kashlan, MD, Dina Poplausky, BA, Angela J. Lamb, MD, Emma Guttman-Yassky, MD, PhD, Nicholas Gulati, MD, PhD

Get full text

IL-17 induces an expanded range of downstream genes in reconstituted human epidermis model. by Andrea Chiricozzi, Kristine E Nograles, Leanne M Johnson-Huang, Judilyn Fuentes-Duculan, Irma Cardinale, Kathleen M Bonifacio, Nicholas Gulati, Hiroshi Mitsui, Emma Guttman-Yassky, Mayte Suárez-Fariñas, James G Krueger

Get full text

International observational atopic dermatitis cohort to follow natural history and treatment course: TARGET-DERM AD study design and rationale by Amy S Paller, Emma Guttman-Yassky, Katrina Abuabara, Jonathan I Silverberg, Eric L Simpson, Lawrence F. Eichenfield, Robert Bissonnette, James Krueger, John E. Harris, Laura Dalfonso, Stephanie E Watkins, Julie M Crawford, D Thaçi

Get full text

The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins by Patrick M. Brunner, Mayte Suárez-Fariñas, Helen He, Kunal Malik, Huei-Chi Wen, Juana Gonzalez, Tom Chih-Chieh Chan, Yeriel Estrada, Xiuzhong Zheng, Saakshi Khattri, Annunziata Dattola, James G. Krueger, Emma Guttman-Yassky

Get full text

Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis by Peter Nash, Atul Deodhar, Philip J Mease, Yoshiya Tanaka, Tim Shaw, Gerd R Burmester, Kevin L Winthrop, Alan D Irvine, Eduardo Mysler, Stanley B Cohen, Ana P Lacerda, John Liu, Hannah Palac, Emma Guttman‑Yassky

Get full text